Similar signaling changes were noted in prostate cancer cells where ABL kinase activation caused a decrease in Rap1 activation via phosphorylation of the CrkII adaptor and disruption of the CrkII/C3G complex resulting in decreased β1-integrin affinity without altering β1-integrin levels [58]. This evidence concerns the gene CRK and prostate carcinoma.